LAWSUITS FILED AGAINST HBNC, IEP and CRL - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / June 1, 2023 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Horizon Bancorp, Inc. (NASDAQ:HBNC)

CONTACT JAKUBOWITZ ABOUT HBNC:
https://claimyourloss.com/securities/horizon-class-action-loss-submission-form/?id=40238&from=1

Class Period : March 9, 2022 - March 10, 2023

Lead Plaintiff Deadline : June 20, 2023

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company maintained deficient internal accounting controls relating to its classification of certain loan balances and securities; (ii) as a result of the foregoing deficiencies, throughout 2022 the Company issued quarterly financial statements containing errors that would require subsequent revision; (iii) restatement of the foregoing financial statements would hinder the Company's ability to timely file its annual report for 2022; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Icahn Enterprises L.P. (NASDAQ:IEP)

CONTACT JAKUBOWITZ ABOUT IEP:
https://claimyourloss.com/securities/icahn-enterprises-class-action-loss-submission-form/?id=40238&from=1

Class Period : August 2, 2018 - May 9, 2023

Lead Plaintiff Deadline : July 10, 2023

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Icahn Enterprises was inflating its net asset value; (ii) the Company was using money taken in from new investors to pay out dividends to old investors; (iii) as a result, the Company would become the subject of criminal and/or regulatory scrutiny; and (iv) as a result of the foregoing, Defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Charles River Laboratories International, Inc. (NYSE:CRL)

CONTACT JAKUBOWITZ ABOUT CRL:
https://claimyourloss.com/securities/charles-river-class-action-loss-submission-form/?id=40238&from=1

Class Period : May 5, 2020 - February 21, 2023

Lead Plaintiff Deadline : July 18, 2023

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887

SOURCE: Jakubowitz Law

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.